NT$ 61.2
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Good growth
Data is available to registered users only
Data is available to registered users only
About
SunWay Biotech Co., LTD. dedicates itself to specialized research and development, coupled with the production and processing of technical materials. The company's primary focus involves the creation and manufacturing of specific bioproducts, including Monascus purpureus NTU 568 and Lactobacillus paracasei subsp. paracasei NTU 101, along with related offerings. Established in 2007, the firm operates from its headquarters in Taipei, Taiwan.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/E
Data is available to registered users only